Pacira BioSciences, Inc. Earnings
The next earnings date for Pacira BioSciences, Inc. is August 5, 2025.
They are scheduled to announce earnings after the market closes that day.
Analyst Estimates of Pacira BioSciences, Inc. Earnings
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Pacira BioSciences, Inc. Earnings: Historical
More About Pacira BioSciences, Inc.
Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. The company has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
“Pacira BioSciences, Inc. Earnings” Can Refer to the Pacira BioSciences, Inc. Earnings Date
Some people say “Pacira BioSciences, Inc. earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Pacira BioSciences, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Pacira BioSciences, Inc. Stock on the Earnings Date
If you own Pacira BioSciences, Inc. stock (PCRX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Pacira BioSciences, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Pacira BioSciences, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Pacira BioSciences, Inc. Earnings
You can contact us any time if you would like to ask questions about Pacira BioSciences, Inc. earnings or anything else related to the stock market.